House Energy & Commerce Relaunches Investigation on Tainted Heparin from China
The House Energy and Commerce Committee announced that it is relaunching its investigation into tainted heparin and calling on the Food and Drug Administration to release documents related to its response to the unsolved case of toxic and sometimes lethal…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
contaminated heparin supplies that were imported from China and given to U.S. patients. In a letter sent to the FDA, Committee Chairman Upton (R), Oversight and Investigations Subcommittee Chairman Stearns (R), and Health Subcommittee Vice Chairman Burgess (R) argued that the public deserves long-overdue answers about the contamination of this blood-thinning drug in order to prevent similar dangers in the future.